To assess the effect of LCP1 on cell invasive ability, Transwell invasion assay were performed in U251 and LN229 cells, showing that LCP1 knockdown markedly reduced the invasive capacity of both glioma cell lines (Figure 9B). Here, LCP1 is linked to central nervous system cancer.